CARLONE, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 978
EU - Europa 217
AS - Asia 208
SA - Sud America 17
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.422
Nazione #
US - Stati Uniti d'America 973
SG - Singapore 92
IT - Italia 70
IN - India 61
SE - Svezia 54
CN - Cina 53
UA - Ucraina 34
FI - Finlandia 32
AR - Argentina 17
RO - Romania 9
IE - Irlanda 6
CA - Canada 5
DE - Germania 5
GB - Regno Unito 3
IR - Iran 2
BG - Bulgaria 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
FR - Francia 1
RU - Federazione Russa 1
Totale 1.422
Città #
Chandler 136
Fairfield 121
Santa Clara 79
Singapore 66
Ashburn 57
Woodbridge 56
San Paolo di Civitate 55
Wilmington 52
Seattle 40
Cambridge 37
Houston 37
Beijing 35
Plano 32
Princeton 32
Boston 31
Lawrence 30
Dearborn 27
Andover 16
Federal 16
Ann Arbor 14
Des Moines 12
Jacksonville 12
San Diego 12
Boardman 9
Millbury 7
Rome 7
Dublin 6
Falls Church 6
Toronto 4
Norwalk 3
Bühl 2
Falkenstein 2
Fort Worth 2
Fuzhou 2
Guangzhou 2
Hefei 2
Kunming 2
Laurel 2
London 2
Nanchang 2
Parma 2
San Mateo 2
Springfield 2
Verona 2
Zanjan 2
Algiers 1
Bern 1
Changsha 1
Chions 1
Fremont 1
Grafing 1
Guiyang 1
Hangzhou 1
Harbin 1
Helsinki 1
Jinan 1
Las Vegas 1
Leawood 1
Mcallen 1
Nanjing 1
Nottingham 1
Ottawa 1
Plattsmouth 1
Pune 1
Sofia 1
Zhengzhou 1
Totale 1.098
Nome #
ATRIAL NATRIURETIC PEPTIDE, RENIN AND ALDOSTERONE IN OBSTRUCTIVE LUNG-DISEASE AND HEART-FAILURE 80
INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units 75
Brain Dysfunction in Respiratory Failure 72
EFFECTS OF FENOTEROL ON OXYGEN-TRANSPORT IN PATIENTS WITH CHRONIC AIR-FLOW OBSTRUCTION 71
Effect of reduced body weight on muscle aerobic capacity in patients with COPD 65
OXYGEN EFFECT ON O-2 DEFICIT AND VO2 KINETICS DURING EXERCISE IN OBSTRUCTIVE PULMONARY-DISEASE 63
EFFECT OF INORGANIC-PHOSPHATE IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE PATIENTS DURING EXERCISE 59
REGULATION OF ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN NORMAL HUMANS 54
CARDIOPULMONARY EXERCISE TESTING IN THE EVALUATION OF PATIENTS WITH VENTILATORY VS CIRCULATORY CAUSES OF REDUCED EXERCISE TOLERANCE 54
THE EFFECT OF OXYGEN ON SODIUM-EXCRETION IN HYPOXEMIC PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG-DISEASE 52
EFFECT OF OXYGEN ON NA+ EXCRETION IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) PATIENTS 49
Incidence of acid-base and electrolyte disturbances in a general hospital: a study of 110 consecutive admissions. 49
EFFECT OF INORGANIC-PHOSPHATE ON THE OXYHEMOGLOBIN (HBO2) AFFINITY OF DOGS 46
NUTRITIONAL STATE AND EXERCISE TOLERANCE IN PATIENTS WITH COPD 45
ATRIAL NATRIURETIC PEPTIDE (ANP) RESPONSE TO INTRATHORACIC PRESSURE (ITP)ELEVATION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) AND IN CHRONIC HEART-DISEASE (CHD) PATIENTS 44
Alveolar cell population in HIV infected patients 44
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy 44
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON SODIUM AND WATER-EXCRETION 41
COMPARISON OF CARDIORESPIRATORY RESPONSES TO O-2 AT REST AND EXERCISE - HYPERCAPNIC VS NORMOCAPNIC OBSTRUCTIVE LUNG-DISEASE PATIENTS 39
[A combination of fenoterol and ipratropium bromide administered by inhalation. Evaluation of its effectiveness and tolerance in a long-term study]. 39
EFFECT OF OXYGEN ON O2 KINETICS AND OTHER CARDIORESPIRATORY PARAMETERS DURING EXERCISE IN COPD 39
TOLERANCE TO INHALED DUOVENT - A LONG-TERM STUDY 36
PHARMACOLOGICAL ELEVATION OF PLASMA INORGANIC-PHOSPHATE IN HYPOXEMIC OBSTRUCTIVE LUNG-DISEASE 36
MODULATION OF ATRIAL NATRIURETIC PEPTIDE RELEASE IN NORMALS 35
PLASMA ATRIAL NATRIURETIC PEPTIDE (ANP), RENIN-ACTIVITY (PRA), AND ALDOSTERONE (PA) IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) 35
Nutritional status and exercise performance in chronic obstructive pulmonary disease (COPD) 35
ANTISHOCK TROUSER INFLATION - HEMODYNAMIC, RENAL AND HORMONAL RESPONSES 35
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON RENAL SODIUM AND WATER-EXCRETION 31
The effect of body weight and arterial hypoxemia on peak oxygen uptake (VO2 peak) and VO2 kinetics (tau VO2) in COPD. 30
Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus 28
Pharmacologic elevation of blood inorganic phosphate (Pi) in hypoxemic patients with COPD. 24
Totale 1.449
Categoria #
all - tutte 4.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 0 26 42 40 32 26 26 21 5
2020/202157 9 11 1 6 0 1 0 8 7 9 5 0
2021/2022322 0 19 23 21 37 5 6 33 33 22 44 79
2022/2023389 62 121 22 46 47 34 5 15 20 4 9 4
2023/202472 11 17 2 2 4 2 1 1 0 16 10 6
2024/2025155 15 7 38 3 92 0 0 0 0 0 0 0
Totale 1.449